Add BrightSurf on Google Email

NUS and A*STAR researchers develop wearable, stretchable sensor for quick, continuous, and non-invasive detection of solid-state skin biomarkers

Scientists created a wearable sensor that can monitor cholesterol and lactate levels on dry skin, enabling early disease detection. The sensor overcomes existing challenges of traditional methods, promising new opportunities for remote patient monitoring and population-wide health screening.

SourceNational University of Singapore·JournalNature Materials·TypeExperimental study·DateAug 19, 2024

Enhanced expression of two ISGs as potential biomarkers of prognosis in HIV-infected immunological non-responders

Researchers found that HIV-infected individuals with impaired immune recovery (INRs) have significantly higher expression of IFI27 and IFI6 in their peripheral blood compared to those who recovered well (IRs). A predictive model using these genes, along with age and CD4+ T/CD8+ T ratio, accurately identified INRs. These findings sugges...

SourceCompuscript Ltd·JournalZoonoses·DateAug 15, 2024

Patients with unexplainable chronic itch have unique blood biomarkers that could eventually lead to new targeted treatments

Researchers have identified lower levels of certain amino acids in the blood plasma of patients with unexplainable chronic itch, offering a potential breakthrough in treating this debilitating condition. These findings may pave the way for new targeted therapies.

SourceUniversity of Maryland School of Medicine·JournalScientific Reports·TypeExperimental study·DateAug 14, 2024

Dealing with runaway metastatic disease

Researchers discuss how PROM2 is a predictive biomarker of distant metastases and shorter survival among patients with stage III melanomas. They also demonstrate that runaway metastasis is closely linked to PROM2 overexpression, through increased epithelial-to-mesenchymal transition marker expression and ferroptosis resistance.

SourceImpact Journals LLC·JournalOncotarget·TypeCommentary/editorial·DateAug 7, 2024

Recent study reveals key immune cells as critical factors in lung cancer prognosis

A recent study published in Frontiers in Immunology highlights the crucial role of tissue-resident memory T cells in non-small cell lung cancer. The research found that these cells can significantly impact patient outcomes and guide personalized treatment strategies, particularly those involving immunotherapy.

SourceTerasaki Institute for Biomedical Innovation·JournalFrontiers in Immunology·TypeData/statistical analysis·DateJul 30, 2024

Hackensack Meridian CDI Lab publishes papers pointing the way toward an exhaled-breath test for lung cancer

Scientists have successfully collected and profiled lung biomarkers from human breath, developing animal models to identify key markers for early detection of metastatic lung tumors. The research establishes a scientific roadmap for an exhaled-breath test, which may revolutionize the diagnosis and surveillance of human lung diseases.

SourceHackensack Meridian Health·JournalJournal of Extracellular Vesicles·TypeExperimental study·DateJul 18, 2024

Key driver for epithelial cancer development identified

A distinct TNF-α signaling program has been identified as a key driver of epithelial cancer development, contributing to cell proliferation and invasion. The researchers found that this program is active in both normal tissues and tumors, but its level of activity correlates with tumor aggressiveness.

SourceUniversity of Zurich·JournalNature·TypeExperimental study·DateJul 17, 2024

Robert A. Rissman, Ph.D., receives the 2024 Alzheimer Award

Dr. Rissman's research uses plasma Aβ42/Aβ40 ratio to predict brain amyloid PET positivity and identify individuals at risk for Alzheimer's disease. His findings demonstrate the potential of a blood test to screen for amyloid in preclinical AD trials.

SourceIOS Press·JournalJournal of Alzheimer’s Disease·TypeMeta-analysis·DateJul 9, 2024

RNAs may help identify stage II colon cancer patients who may benefit from chemotherapy following surgery

A new study has identified specific RNAs that may help identify stage II colon cancer patients who are likely to benefit from chemotherapy following surgery. The researchers found that certain housekeeping RNAs were up-regulated in patients with recurrence, suggesting their potential role in the metastatic process.

SourceElsevier·JournalAmerican Journal Of Pathology·TypeExperimental study·DateJul 8, 2024

AI model finds the cancer clues at lightning speed

Researchers at the University of Gothenburg developed an AI model called Candycrunch to automate the analysis of glycan structures in cancer cells. The model can identify abnormal structures and biomarkers in just a few seconds, accelerating the discovery of new treatments.

SourceUniversity of Gothenburg·JournalNature Methods·TypeComputational simulation/modeling·DateJul 1, 2024

Scientists identify molecules associated with recurrence in blood samples from malaria patients

Researchers analyzed blood plasma samples from 110 patients infected with Plasmodium vivax to understand how metabolisms were affected during initial episodes versus recurrent cases. The study found that patients with recurrence exhibited modulation in lipid pathways involved in immune system production, while those with first-episode ...

Clinical ageing clocks: NUS and SGH develop algorithm-powered tests to indicate mortality risk

Researchers developed two clinical ageing clocks, PCAge and LinAge, that use blood tests, a urine test, and a health questionnaire to estimate future mortality risk. These clocks show significant predictive efficacy in characterising individual future ageing trajectories.

SourceNational University of Singapore, Yong Loo Lin School of Medicine·JournalNature Aging·TypeData/statistical analysis·DateJun 19, 2024

Blood test could predict Parkinson’s seven years before symptoms

A team of researchers has developed a simple blood test that uses artificial intelligence (AI) to predict Parkinson's disease up to seven years before the onset of symptoms. The test analyzes a panel of eight blood-based biomarkers with concentrations altered in patients with Parkinson's, providing a diagnosis with 100% accuracy.

SourceUniversity College London·JournalNature Communications·TypeExperimental study·DateJun 18, 2024

Blood markers detect rare forms of dementia as well as the neurological diseases ALS and PSP

Researchers have developed a blood test that can detect rare forms of dementia, such as frontotemporal dementia (FTD) and progressive supranuclear palsy (PSP), as well as amyotrophic lateral sclerosis (ALS). The test uses biomarkers, including tau and TDP-43 proteins, to identify underlying pathology.

SourceDZNE - German Center for Neurodegenerative Diseases·JournalNature Medicine·TypeObservational study·DateJun 18, 2024

New screening tool could improve the survival rate of patients with hepatocellular carcinoma from 20% to 90%

A new machine-learning model using serum fusion-gene levels predicts HCC with an accuracy of 83-91%, significantly improving upon current biomarkers like serum alpha-fetal protein. This breakthrough tool may help identify patients at risk and monitor cancer recurrence, leading to improved survival rates.

SourceElsevier·JournalAmerican Journal Of Pathology·TypeComputational simulation/modeling·DateJun 17, 2024

Omics research and AI tools are contributing to our understanding of what causes Alzheimer’s disease

The study highlights the potential of omics research and AI tools to disentangle the molecular drivers of Alzheimer’s disease. Key findings include the identification of novel biomarkers for early detection and therapeutic targets, as well as the exploration of genetic factors contributing to AD risk and progression.

SourceIOS Press·JournalJournal of Alzheimer’s Disease·TypeData/statistical analysis·DateJun 12, 2024

Association for Molecular Pathology publishes evidence-based recommendations for tumor mutational burden testing

The Association for Molecular Pathology has published guidelines for tumor mutational burden (TMB) testing, aiming to standardize calculation and reporting of TMB as a predictive biomarker for immune checkpoint inhibitor therapies. These recommendations emphasize the importance of comprehensive methodological descriptions in publications.

SourceAssociation for Molecular Pathology·JournalJournal of Molecular Diagnostics·DateJun 6, 2024

Pro-inflammatory diets are associated with higher levels of the heart failure biomarker NT-proBNP, with potential implications for cardiovascular risk, per study of more than 10,000 US adults

A study of over 10,000 US adults found a strong association between pro-inflammatory diets and elevated NT-proBNP levels, indicating potential increased cardiovascular risk. The research suggests that dietary inflammatory index may be an important factor in heart failure biomarker levels.

SourcePLOS·JournalPLOS ONE·DateJun 5, 2024

BTK inhibitor-related cardiotoxicity: the quest for predictive biomarkers and improved risk stratification

Researchers discuss Ibrutinib, a BTK inhibitor approved for chronic lymphocytic leukemia treatment, noting 20-25% of patients experience dose-limiting cardiovascular toxicities. A recent study identifies genetic biomarkers, such as KCNQ1 and GATA4, associated with cardiotoxic events, which may improve risk stratification.

SourceImpact Journals LLC·JournalOncotarget·TypeCommentary/editorial·DateJun 4, 2024

White blood cell “nets” could be early warning sign of major immunotherapy complication

A study from Michigan Medicine reveals a connection between neutrophil activation and severe cytokine release syndrome (CRS), a potentially life-threatening reaction to CAR T-Cell therapy. Researchers identified biomarkers of NETosis, a process in which neutrophils create webs that may contribute to CRS.

SourceMichigan Medicine - University of Michigan·JournalBlood Advances·TypeExperimental study·DateJun 3, 2024